Conclusion
A standard patient follow-up algorithm has not yet been determined for
post-COVID-19 treatment. The necessity for follow-up of the symptoms of
the disease that appear at the treatment and persist after the treatment
should be demarcated. It is also important to differentiate to avoid the
financial and sociological burden of post-treatment follow-up
requirement. In this context, post-treatment follow-up algorithms should
be determined. There is a need for specially designed comparative and
evidence-based randomized clinical trials to determine a post-treatment
follow-up algorithm for COVID-19 disease whose chronic effects have not
yet been clarified.